Chantal Alcouffe

USPTO Granted Patents = 9 (Patent Applications = 2)

CIPO Patents = 3 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 5)

Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 13(Granted Patents)

Location History:

Roquettes, FR (2009 - 2014)
Paris, FR (2014 - 2018)

Company Filing History:

Years Active: 2009-2018

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10138235 - Pyrazolopyridine derivatives, preparation process therefor and therapeutic use thereof (2018-11-27),

2. 9732078 - Therapeutic use of imidazopyridine derivatives (2017-08-15),

3. 9572799 - Pyrazolopyridine derivatives for use in the treatment of bladder cancer (2017-02-21),

4. 9452164 - Imidazopyridine derivatives, process for preparation thereof and therapeutic use thereof (2016-09-27),

5. 8859544 - Indolizine derivatives, process for the preparation thereof and therapeutic use thereof (2014-10-14),

6. 8759344 - Imidazopyridine derivatives, process for preparation thereof and therapeutic use thereof (2014-06-24),

7. 8633216 - Imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same (2014-01-21),

8. 8008321 - Imidazo[1,5-a] pyridine derivatives, method for preparing same and pharmaceutical compositions containing same (2011-08-30),

9. 7553845 - Substituted indolizine 1,2,3,6,7,8 derivatives, FGFs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives (2009-06-30),

Title: Chantal Alcouffe: Innovator in Medicinal Chemistry

Introduction

Chantal Alcouffe is a prominent inventor based in Paris, France. She has made significant contributions to the field of medicinal chemistry, particularly in the development of therapeutic compounds. With a total of 9 patents to her name, Alcouffe's work has the potential to impact the treatment of various diseases.

Latest Patents

Among her latest patents, Alcouffe has developed pyrazolopyridine derivatives, which are FGF-inhibiting compounds. This invention includes a preparation process and therapeutic applications. Additionally, she has worked on imidazopyridine derivatives, which are used in the formulation of medications for treating bladder cancer. These innovations highlight her commitment to advancing medical science through her research.

Career Highlights

Chantal Alcouffe has had a successful career, working with notable companies such as Sanofi and Sanofi-Aventis. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Throughout her career, Alcouffe has worked alongside talented colleagues, including Corentin Herbert and Gilbert Lassalle. These collaborations have enriched her research and expanded her impact in the field of medicinal chemistry.

Conclusion

Chantal Alcouffe's innovative work in medicinal chemistry and her numerous patents demonstrate her dedication to improving healthcare. Her contributions are paving the way for new treatments and therapies that could benefit many patients in the future.

This text is generated by artificial intelligence and may not be accurate.